-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) continues to evolve, leading to the emergence of variants of interest (VOCs), variants of concern, and variants of surveillance
.
These variants can increase viral transmission, immune evasion and/or disease severity
.
Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) continues to evolve, leading to the emergence of variants of interest (VOCs), variants of concern, and variants of surveillance
Figure 1 Reduced neutralization of omilon SARS-CoV-2 by previous non-omilon virus infection
.
The 50% fluorescence foci neutralization titer (FFRNT50) was determined in the serum of two groups of patients previously infected with non-Omicron SARS-CoV-2
.
The lower cross-neutralization of Ogilvy compared to previous non-Ogilvy infection supports the vaccination of previously infected individuals to mitigate the health effects of an ongoing Ogilvy surge
Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection leave a comment here